Cetuximab and panitumumab, which target the epidermal growth factor receptor (EGFR), are used to treat colorectal cancer and head and neck cancers (Markman et al., 2009[87]; Martinelli et al., 2009[88]). The gene discussed is EGFR; the disease is head and neck cancer.